schizophrenia
Conditions
Interventions
Patients are switched from prior antipsychotics to aripiprazole
Sponsors
Department of Psychiatry, Graduate School of Medicine, Kyoto University
Kitano Hospital:The Tazuke Kofukai medical Research Institute,Takashima General hospital,Ueno Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -participants who meet the criteria for schizophrenia according to the DSM ver.4 -participants who are ongoing treatment and are considered that they should change the medicine for clinical reasons -Participants who are either inpatients or outpatients
Exclusion criteria
Exclusion criteria: -articipants under the comatose state -participants under the strong influence of central nervous system depressant -participants in administration of epinephrine -participants who have a histry of allergy for aripiprazole -participants who are contacting diabetes mellitus, or have a medical history of diabetes mellitus -participants who are during pregnancy or possibility of pregnancy -the attending doctor appraise participants for inadequate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Brief Psychiatric Rating Scale: BPRS, Clinical global impression : CGI-S and I, Drug-Induced Extrapyramidal Symptoms Scale: DIEPSS Japanese Version for the Schizophrenia Quality of Life Scale: JSQLS | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug Attitude Inventory:DAI-10 Preference of medicine Questionnaire:POM Body Weight,Body Mass Index,Blood Glucose,Prolactin | — |
Countries
Japan
Outcome results
None listed